Immunovia Names Natalie Carfora VP of Market Access and Reimbursement Ahead of PancreaSure Launch

Immunovia has appointed Natalie Carfora as Vice President of Market Access and Reimbursement to secure coverage and reimbursement for its new PancreaSure test in the US. Carfora returns to Immunovia after a stint at Lucid Diagnostics, where she secured the first positive policy decision for an esophageal DNA test and worked on Medicare coverage initiatives. Her role is critical to Immunovia's business, with a proven track record of success.

Lund, Sweden – Immunovia (publ.) has appointed Natalie Carfora as Vice President, Market Access and Reimbursement, a critical role aimed at securing U.S. coverage and reimbursement for the company's PancreaSure test. Carfora returns to Immunovia after leading market access at Lucid Diagnostics, where she secured the first positive policy decision for an esophageal DNA test and successfully guided Medicare coverage reconsideration [2].

Jeff Borcherding, CEO of Immunovia, highlighted the significance of Carfora's appointment: "This recruitment is business-critical for us. Natalie brings exceptional expertise, deep familiarity with Immunovia, and a proven track record of success," he said [1].

Carfora's extensive experience in market access and sales in medical diagnostics will be instrumental in navigating the reimbursement process for PancreaSure. She has a history of engaging with commercial and governmental payors on coverage policy and has led market access initiatives, including clinical study design collaboration and payor pilot programs [2].

The appointment comes as Immunovia prepares to launch the PancreaSure test, which aims to detect pancreatic cancer at an early stage. The U.S. market is critical for Immunovia, with an estimated 1,8 million individuals who could benefit from the test annually [1].

Carfora expressed enthusiasm about her return to Immunovia: "I'm excited to return at a time when there's real momentum building here. As the launch of the PancreaSure test approaches and the reimbursement process moves forward, my experiences will help us navigate with speed and purpose," she said [1].

References:
[1] https://www.tradingview.com/news/reuters.com,2025-07-21:newsml_MFN9kC9F2:0-immunovia-appoints-natalie-carfora-as-vp-market-access-and-reimbursement/
[2] https://mfn.se/a/immunovia/immunovia-utser-natalie-carfora-till-vp-market-access-and-reimbursement